–
Trevi Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.5
FY22:
−29.9
FY23:
−33.9
FY24:
−51.5
FY25:
−49.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.8
FY22:
−27.8
FY23:
−28.6
FY24:
−47.8
FY25:
−42.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−34.0
FY22:
−29.2
FY23:
−29.1
FY24:
−47.9
FY25:
−42.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−33.9
FY22:
−29.2
FY23:
−29.1
FY24:
−47.9
FY25:
−42.8
All amounts in millions USD